Using saliva to predict lung complications in premature infants
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants
This study is looking at how tiny molecules in saliva might help doctors predict lung problems in premature babies, so they can catch issues early and provide better care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-10895439 on NIH RePORTER |
What this research studies
This research investigates the use of salivary microRNAs as potential markers to predict pulmonary hypertension associated with bronchopulmonary dysplasia in extremely low gestational age infants. By analyzing saliva samples, the study aims to identify non-invasive biomarkers that can help healthcare providers assess the risk of developing severe lung complications in these vulnerable infants. The approach focuses on early detection, which could lead to timely interventions and improved management of affected infants. The research will involve collecting saliva samples and correlating the findings with clinical outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are extremely low gestational age infants who are at risk for developing bronchopulmonary dysplasia and pulmonary hypertension.
Not a fit: Patients who are not extremely low gestational age infants or those who do not have bronchopulmonary dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and better management of lung complications in premature infants, potentially reducing morbidity and mortality.
How similar studies have performed: Previous research has shown promise in using biomarkers for predicting outcomes in similar patient populations, indicating that this approach may be viable.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Siddaiah, Roopa — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Siddaiah, Roopa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.